The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data

Cannabinoid Receptor 1 (CNR1) Gene Polymorphisms in Schizophrenia Patients: Rs6454674 Polymorphism is Associated with Disease Severity

(2015) Umit Sertan Copoglu et al.   KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY

Erratum: Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients

(2015) J Frank et al.   MOLECULAR PSYCHIATRY

Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms

(2015) Paula Suárez-Pinilla et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Psychotomimetic effects at initiation of cannabis use are associated with cannabinoid receptor 1 (CNR1) variants in healthy students

(2014) M O Krebs et al.   MOLECULAR PSYCHIATRY

CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia

(2013) Weiping Yu et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia

(2012) Marta Costa et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The CNR1 gene in depression and schizophrenia — Is there an association with early improvement and response?

(2012) Rebecca Schennach et al.   PSYCHIATRY RESEARCH

Genetics of Schizophrenia: New Findings and Challenges

(2011) Pablo V. Gejman et al.   Annual Review of Genomics and Human Genetics

Relation of G1359A polymorphism of the cannabinoid receptor (CB1) gene with metabolic syndrome by ATP III classification

(2011) D. A. de Luis et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain

(2011) Young-Min Park et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia

(2011) A K Tiwari et al.   PHARMACOGENOMICS JOURNAL

Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia

(2011) Beng-Choon Ho et al.   SCHIZOPHRENIA RESEARCH

CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis

(2010) Amine Benyamina et al.   ADDICTION BIOLOGY

Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of CannabisSibling Analysis and Proband Follow-upGenetic Variation Underlying Cannabis Effects

(2010) Ruud van Winkel   ARCHIVES OF GENERAL PSYCHIATRY

Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia

(2010) Monica Rais et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Endocannabinoid Pro129Thr FAAH Functional Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With Antipsychotic-Induced Weight Gain

(2010) Palmiero Monteleone et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR

(2010) Dean F. Wong et al.   NEUROIMAGE

A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia

(2010) Arun K Tiwari et al.   NEUROPSYCHOPHARMACOLOGY

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults

(2009) Christie A. Hartman et al.   DRUG AND ALCOHOL DEPENDENCE

Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study

(2009) Paul Lichtenstein et al.   LANCET

Role of cannabis and endocannabinoids in the genesis of schizophrenia

(2009) Emilio Fernandez-Espejo et al.   PSYCHOPHARMACOLOGY

Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity

(2009) N. D. Volkow   SCHIZOPHRENIA BULLETIN

Advances in the field of cannabinoid-opioid cross-talk

(2008) Patricia Robledo et al.   ADDICTION BIOLOGY

Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia

(2008) Iván Chavarría-Siles et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations

(2008) Michael Benzinou et al.   HUMAN MOLECULAR GENETICS

The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia

(2007) Nora Hamdani et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY